AU Patent

AU2018282427A1 — Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist

Assigned to Glaxo Group Ltd · Expires 2019-01-17 · 7y expired

What this patent protects

A composition comprising a compound of the formula: Compound (1) wherein X- is a pharmaceutically acceptable anion; and a compound of the formula: HO CHCH 2NH(CH 2)6O(CH2)2OCH2 or a pharmaceutically acceptable salt thereof (Compound (11)).

USPTO Abstract

A composition comprising a compound of the formula: Compound (1) wherein X- is a pharmaceutically acceptable anion; and a compound of the formula: HO CHCH 2NH(CH 2)6O(CH2)2OCH2 or a pharmaceutically acceptable salt thereof (Compound (11)).

Drugs covered by this patent

Patent Metadata

Patent number
AU2018282427A1
Jurisdiction
AU
Classification
—
Expires
2019-01-17
Drug substance claim
No
Drug product claim
No
Assignee
Glaxo Group Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.